Aimei Health Technology C... (AFJK)
11.00
0.00 (0.00%)
At close: Mar 20, 2025, 11:40 AM
Company Description
Aimei Health Technology Co., Ltd does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Aimei Health Technology Co. Ltd
| Country | United States |
| IPO Date | n/a |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Junheng Xie |
Contact Details
Address: 10 East 53rd Street New York, New York United States | |
| Website | n/a |
Stock Details
| Ticker Symbol | AFJK |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001979005 |
| CUSIP Number | n/a |
| ISIN Number | KYG013411098 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Junheng Xie | Chief Executive Officer, Secretary & Director |
| Heung Ming Wong | Chief Financial Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 07, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Mar 07, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Mar 06, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G | Filing |
| Feb 14, 2025 | SCHEDULE 13G | Filing |
| Feb 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 13, 2025 | SCHEDULE 13G | Filing |
| Feb 11, 2025 | 4 | Filing |
| Feb 11, 2025 | 3 | Filing |
| Feb 07, 2025 | 8-K | Current Report |